Stereotactic Body Radiotherapy in Non-Small Cell Lung Cancer Patients: Assessment of Response and Toxicity at Single İnstitution

Basit Öğe Kaydı
dc.contributor.authorEkici, Kemal
dc.contributor.authorKömürcüoğlu, Berna
dc.contributor.authorÖlmezoğlu, Ali
dc.date.accessioned2024-05-19T14:23:33Z
dc.date.available2024-05-19T14:23:33Z
dc.date.issued2022
dc.departmentİstinye Üniversitesien_US
dc.description.abstractObjective: The aim of this study is to assess the efficacy and acute toxicity of stereo tactic body radiotherapy (SBRT) for either primary or metastatic masses of lung tumors. Material and Methods: Analysis was performed on 110 lung tumor masses (primarily non-small cell origin, a small proportion was metastatic) patients treated by CyberKnife® in our clinic between February 2010 and July 2015. Doses had been delivered ranged 20–60 Gy, in one to seven once-daily fractions, depending on tumor size and location. Results: The median follow-up duration after SBRT was 29 months (range 14, 75–40 months). The median overall survival (OS) was 31.62 months (95% CI, 24.06–37.93 months). 3-year survival was 42% and 5-year survival was 22%. Conclusion: Lung tumors (primary or metastatic) treated by SBRT had better treat ment response and less toxicity compared with conventional radiotherapy schedules. If available-depending on size and location of the tumor(s) - SBRT is the most afford able; preferable option.en_US
dc.identifier.doi10.14744/IGH.2022.21033
dc.identifier.endpage98en_US
dc.identifier.issn1300-4115
dc.identifier.issue2en_US
dc.identifier.startpage92en_US
dc.identifier.trdizinid1121527en_US
dc.identifier.urihttps://doi.org/10.14744/IGH.2022.21033
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1121527
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4025
dc.identifier.volume36en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofİzmir Göğüs Hastanesi Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240519_kaen_US
dc.titleStereotactic Body Radiotherapy in Non-Small Cell Lung Cancer Patients: Assessment of Response and Toxicity at Single İnstitutionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu